Rezdiffra vs Motegrity
A side-by-side look at two gastrointestinal medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Rezdiffra | US Motegrity |
|---|---|---|
| Generic name | resmetirom Unverified catalogue summary (Generic name) for Rezdiffra in US; not checked against current local product information. | prucalopride Unverified catalogue summary (Generic name) for Motegrity in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Rezdiffra in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Motegrity in US; not checked against current local product information. |
| Treats | Metabolic dysfunction-associated steatohepatitis (MASH) Unverified catalogue summary (Treats) for Rezdiffra in US; not checked against current local product information. | Chronic idiopathic constipation Unverified catalogue summary (Treats) for Motegrity in US; not checked against current local product information. |
| Category | Gastrointestinal Unverified catalogue summary (Category) for Rezdiffra in US; not checked against current local product information. | Gastrointestinal Unverified catalogue summary (Category) for Motegrity in US; not checked against current local product information. |
| Manufacturer | Madrigal Pharmaceuticals Unverified catalogue summary (Manufacturer) for Rezdiffra in US; not checked against current local product information. | Takeda Unverified catalogue summary (Manufacturer) for Motegrity in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Rezdiffra in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Motegrity in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Rezdiffra in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Motegrity in US; not checked against current local product information. |
| Est. TV ad spend | — | — |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Rezdiffra in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Motegrity in US; not checked against current local product information. |
Rezdiffra
Motegrity
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Rezdiffra or Motegrity better?
This directory does not compare clinical effectiveness or safety. Listing Rezdiffra and Motegrity together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Rezdiffra and Motegrity?
The table shows catalogue identification and estimated advertising information for Rezdiffra and Motegrity, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Rezdiffra has the larger estimated TV advertising budget of the two.